NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis.
- Published in:
- Oncogene, 2012, v. 31, n. 32, p. 3733, doi. 10.1038/onc.2011.542
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2012 AND VI 31 AND IP 32
Results: 7
1
2
Abnormal MDMX degradation in tumor cells due to ARF deficiency.
- Published in:
- Oncogene, 2012, v. 31, n. 32, p. 3721, doi. 10.1038/onc.2011.534
- By:
- Publication type:
- Article
3
Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases.
- Published in:
- Oncogene, 2012, v. 31, n. 32, p. 3655, doi. 10.1038/onc.2011.532
- By:
- Publication type:
- Article
4
A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.
- Published in:
- Oncogene, 2012, v. 31, n. 32, p. 3696, doi. 10.1038/onc.2011.528
- By:
- Publication type:
- Article
5
Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis.
- Published in:
- Oncogene, 2012, v. 31, n. 32, p. 3679, doi. 10.1038/onc.2011.545
- By:
- Publication type:
- Article
6
BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.
- Published in:
- Oncogene, 2012, v. 31, n. 32, p. 3667, doi. 10.1038/onc.2011.531
- By:
- Publication type:
- Article
7
Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties.
- Published in:
- Oncogene, 2012, v. 31, n. 32, p. 3709, doi. 10.1038/onc.2011.529
- By:
- Publication type:
- Article